Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
|||||||
GSM8462825 |
input
|
SRA | 1 | Mark Maienschein-Cline | Jan 28, 2025 | ||||
GSM8462826 |
control_no-treat
|
SRA | 1 | Mark Maienschein-Cline | Jan 28, 2025 | ||||
GSM8462827 |
MRSA_no-treat
|
SRA | 1 | Mark Maienschein-Cline | Jan 28, 2025 | ||||
GSM8462828 |
MRSA_Tys
|
SRA | 1 | Mark Maienschein-Cline | Jan 28, 2025 | ||||
GSM8462829 |
Control_Tys
|
SRA | 1 | Mark Maienschein-Cline | Jan 28, 2025 | ||||
GSM7118068 |
Co-1
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118069 |
Co-2
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118070 |
EB-1
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118071 |
EB-2
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118072 |
HCo-1
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118073 |
HCo-2
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118074 |
HCo-3
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118075 |
HEB-1
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118076 |
HEB-2
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM7118077 |
HEB-3
|
SRA | 1 | Mark Maienschein-Cline | Aug 30, 2023 | ||||
GSM5288816 |
6A3_E2_Plus_DOX_Minus_ICI_Invaded_cells_replicate_1
|
SRA | 1 | Mark Maienschein-Cline | Jun 29, 2022 | ||||
GSM5288817 |
6A3_E2_Plus_DOX_Minus_ICI_Invaded_cells_replicate_2
|
SRA | 1 | Mark Maienschein-Cline | Jun 29, 2022 | ||||
GSM5288818 |
6A3_E2_Plus_DOX_Minus_ICI_Non_Invaded_cells_replicate_1
|
SRA | 1 | Mark Maienschein-Cline | Jun 29, 2022 | ||||
GSM5288819 |
6A3_E2_Plus_DOX_Minus_ICI_Non_Invaded_cells_replicate_2
|
SRA | 1 | Mark Maienschein-Cline | Jun 29, 2022 | ||||
GSM5288820 |
6A3_E2_Plus_DOX_Plus_ICI_Invaded_cells_replicate_1
|
SRA | 1 | Mark Maienschein-Cline | Jun 29, 2022 |